Back to search results

Peer Support for Mental Health in Hormone Care

This study is looking at whether a peer support program can help improve mental health for people receiving hormone care who also experience mild depression or anxiety. You might be able to join if you are 18 or older, speak English, are receiving hormone care in Michigan, and have mild depression or anxiety symptoms (based on specific questionnaires). The study will compare a "peer support group" where you're matched with a mentor, to "Enhanced Usual Care" which provides community resources but no peer support. The main goal is to see if the peer support program is acceptable and practical, and if it can improve mental health. This study plans to enroll 100 participants.

Study design
This study is an interventional study that will randomly assign participants to either a peer support group or an enhanced usual care group. It plans to enroll 100 participants.
What's involved
If you join, you will participate in the study for 6 months. If in the peer support group, you will have sessions with a peer mentor, suggested once a month or more as needed.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months, with assessments at the beginning and at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07354113

Feasibility and Acceptability of Peer Intervention for Improving Mental Health Among People Accessing Hormone Care

Active, Not Recruiting
NAAges 18+InterventionalTreatment
University of Michigan
~100 participants
Updated 2026-06-26 on ClinicalTrials.gov
What's tested:Peer support groupEnhanced Usual Care (EUC)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility assessed by Acceptability based on the average total Abbreviated Acceptability Rating Profile (AARP) score at 6 months
Measured over 6 months
+4 more outcomes measured

Conditions

Hormone Care
Mild Depression
Anxiety

Explore related trials

AnxietyDepressionHormone Care

NCT07354113

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Michigan

    Ann Arbor, Michiganno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Daphna Stroumsa, MD, MPH, MSc · PRINCIPAL_INVESTIGATOR · University of Michigan

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with hormone condition aged 18 years or older and English speaking
Initiating or receiving hormone care in Michigan
Report mild depression or anxiety symptoms, as determined by:
Interest or willingness to participate in peer support group meetings either in-person or virtually

Exclusion

Unable to provide informed consent for any reason
Not fluent in English
Determination by patient's attending healthcare provider that peer mentorship is not appropriate due to unstable psychosis, cognitive disorder, or severe personality disorder, or other issue
At imminent risk of suicide, as determined by active suicide ideation with intent and/or a specific plan (endorsed Columbia Suicide Severity Rating Scale number 4 or number 5 in the past month, number 6 in the past 3 months, or spontaneous report)
Already receiving or intending to receive formalized individual peer specialist services through another community mental health program or organization
Residing outside of the state of Michigan, or planning to move out of the state of Michigan in the next 6 months

What this trial measures

  • Feasibility assessed by Acceptability based on the average total Abbreviated Acceptability Rating Profile (AARP) score at 6 months6 months

    The 9-item AARP is adapted to specifically address this peer support intervention for individuals seeking hormone care. Participants will respond to a 6-point Likert scale rating participants agreement with each acceptability statement. Total scores range from 9-54 with a higher score indicating greater acceptability.

  • Feasibility based on the number of participants that agreed to participate on the study out of total number of individuals approached for study participation.Up to 6 months (recruitment period)
  • Feasibility assessed by Practicality based on the total number of one-on-one in-person sessions vs one-on-one virtual sessions6 months

    This is defined as the total number of one-on-one in-person sessions vs one-on-one virtual sessions.

  • Feasibility assessed by Practicality based on the total the number participants engaged with group sessions in-person vs. number of participants engaged virtually6 months

    This is defined as the total number of participants engaged with group sessions in-person vs. number of participants engaged virtually.

  • Safety based on the number of related adverse events6 months

    Related events included will be definitely, probably, and possibly related events (defined per protocol). The grading scale that will be used for these events include: 1. \- Mild adverse event (AE) - No treatment needed 2. \- Moderate AE - Resolved with treatment 3. \- Severe AE - Inability to carry on normal activities, required professional medical attention 4. \- Life-threatening or disabling AE 5. \- Fatal AE